InvestorsHub Logo
Followers 23
Posts 2626
Boards Moderated 0
Alias Born 12/28/2014

Re: None

Sunday, 02/15/2015 1:23:54 AM

Sunday, February 15, 2015 1:23:54 AM

Post# of 55245
Site Under Construction

Therapy Cells INC

DrPatrick J Casey CSO,Director, Therapy Cells
San Francisco Bay Area
Biotechnology

John Meredith CFO,Director, Therapy Cells
Venice, Florida
Biotechnology

I stated it could get to 2-5 cent with FDA TESTING this year and with FDA approval 5-50 cent and maybe more

Business Description
Therapy Cells Inc holds a license to
US patent 8,372,644 on the process of multiplying Mature Adult Cells for the repair of parts of the body which have been damaged by trauma or
disease. They are currently in the final stages of testing their product for equine and eventually human applications before applying for
approvals for clinical use.
Business Summary
Therapy Cells, Inc. is a development-stage company. The Company is primarily
involved in the cell repair and cell replacement in Equine stock. The
Company’s products are being utilized for the repair of horse’s tendons. The Company has two subsidiaries: Serengeti, Inc and Therapy Cells
Ltd. As of June 30, 2014, Serengeti, Inc is a wholly owned subsidiary of the Company and is located in the United States. Therapy Cells Ltd is a 90.9% owned subsidiary of the Company, as of June 30, 2014. Therapy Cells Ltd is located in New Zealand.




I Only have one post per day